Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: Randomised controlled trial

British Journal of Psychiatry

Volumn 197, Issue 4, 2010, Pages 297-304

  Hollinghurst, Sandra ^a   Peters, Tim J ^a   Kaur, Surinder ^a   Wiles, Nicola ^b   Lewis, Glyn ^b   Kessler, David ^c  

^a Academic Unit of Primary Health Care   (United Kingdom)

^b Academic Unit of Psychiatry   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NATIONAL HEALTH SERVICE; ONLINE ANALYSIS; OUTCOME ASSESSMENT; PATIENT CARE; PRODUCTIVITY; PSYCHOTHERAPIST; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; COGNITIVE THERAPY; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; MEDICAL RECORDS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; QUALITY-ADJUSTED LIFE YEARS; SICK LEAVE; STATE MEDICINE; THERAPY, COMPUTER-ASSISTED; YOUNG ADULT;

EID: 77957675037     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.109.073080     Document Type: Article

References (35)

1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289: 3095-105. (Pubitemid 37432885)
2. National Collaborating Centre for Mental Health. Depression: Management of Depression in Primary and Secondary Care. National Institute for Clinical Excellence, 2004.
3. McCrone P, Dhanasiri S, Patel A, Knapp M, Lawton-Smith S. Paying the Price. The Cost of Mental Health Care in England to 2006. King's Fund, 2008.
4. Hollinghurst S, Kessler D, Peters TJ, Gunnell DJ. The opportunity cost of antidepressant prescribing. BMJ 2005; 330: 999-1000.
5. Medicines and Healthcare products Regulatory Agency. Selective Serotonin Reuptake Inhibitors (SSRIs): Overview of Regulatory Status and CSM Advice Relating to Major Depressive Disorder (MDD) in Children and Adolescents Including a Summary of Available Safety and Efficacy Data. MHRA, 2005 (http://www.mhra.gov.uk/safetyinformation/Safetywarningsalertsandrecalls/ Safetywarningsandmessagesformedicines/CON019494).
6. King M, Sibbald B, Ward E, Bower P, Lloyd M, Gabbay M, et al. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care. Health Technol Assess 2000; 4: 1-83.
7. Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technol Assess 2001; 5: 1-173.
8. Department of Health. Improving Access to Psychological Therapies (IAPT) Commissioning Toolkit. Department of Health, 2010 (http://www.iapt.nhs.uk/).
9. McCrone P, Knapp M, Proudfoot J, Ryden C, Cavanagh K, Shapiro DA, et al. Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry 2004; 185: 55-62. (Pubitemid 38951630)
10. Gerhards SAH, de Graf LE, Jacobs LE, Severens JL, Huibers MJH, Arntz A, et al. Economic evaluation of online computerised cognitive-behavioural therapy without support for depression in primary care: randomised trial. Br J Psychiatry 2010; 196: 310-8.
11. Kessler D, Lewis G, Kaur S, Wiles N, King M, Weich S, et al Therapist-delivered internet psychotherapy for depression in primary care: a randomised controlled trial. Lancet 2009; 374: 628-34.
12. Beck A, Steer R, Brown G. Manual for the Beck Depression Inventory. The Psychological Corporation, 1987.
13. Lewis G, Pelosi AJ, Araya R, Dunn G. Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med 1992; 22: 465-86.
14. Beck J. Cognitive Therapy, Basics and Beyond. Guilford Press, 1995.
15. Blackburn IM, James IA, Milne DL, Baker C, Standart S, Garland A, et al. The revised cognitive therapy scale (CTS-R): psychometric properties. Behav Cogn Psychother 2001; 29: 431-46. (Pubitemid 33622377)
16. Brooks R. Euroqol: the current state of play. Health Policy 1996; 37: 53-72.
17. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. NICE, 2008 (http://www.nice.org.uk/media/B52/ A7/TAMethodsGuideUpdatedJune2008.pdf).
18. Dolan P, Gudex C, Kind P, Williams A. A Social Tariff for EuroQol. Results from a UK General Population Survey. Centre for Health Economics, University of York, 1995.
19. Curtis L. Unit Costs of Health and Social Care 2007. PSSRU, University of Kent, 2008.
20. Salisbury C, Chalder M, Manku-Scott T, Nicholas R, Deave T, Noble S, et al. The National Evaluation of NHS Walk-in Centres. Final Report. University of Bristol, 2002 (http://www.epi.bris.ac.uk/wic/pdf/WIC%20Evaluation%20Report%20- %20Final.pdf).
21. Munro J, Nicholl J, O'Cathain A, Knowles E, Morgan A. Evaluation of NHS Direct First Wave Sites: Final Report of the Phase 1 Research. Medical Care Research Unit, University of Sheffield, 2001 (http://www.sheffield.ac.uk/ content/1/c6/02/40/50/nhsd3.pdf).
22. Department of Health. National Schedule of Reference Costs. Department of Health, 2007 (http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-4127649).
23. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary (issue 54). BMJ Group and Pharm Press, 2007 (http://www.bnf.org/bnf/).
24. The Automobile Association. Running Cost Tables. AA, 2007 (http://www.theaa.com/motoring-advice/running-costs/index.html).
25. Office for National Statistics. Annual Survey of Hours and Earnings (ASHE) - 2007 Results. ONS, 2007 (http://www.statistics.gov.uk/pdfdir/ashe1107. pdf).
26. Pritchard C, Sculpher M. Productivity Costs: Principles and Practice in Economic Evaluation. Office of Health Economics, 2000.
27. van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999; 18: 681-94.
28. Briggs AH. A Bayesian approach to stochastic cost-effectiveness analysis. An illustration and application to blood pressure control in type 2 diabetes. Intl J Tech Assess 2001; 17: 69-82.
29. Simon G, Ludman J. It's time for disruptive innovation in psychotherapy. Lancet 2009; 374: 594-5.
30. Bosmans J, van Schaik D, de Bruijne M, Van Hout H, van Marwijk H, van Tulder M, et al. Are psychological treatments for depression in primary care cost-effective? J Ment Health Policy Econ 2008; 11: 3-15.
31. Bower P, Byford S, Sibbald B, Ward E, King, M, Lloyd M. Randomised controlled trial of non-directive counselling, cognitive-behavioural therapy, and usual general practitioner care for patients with depression. II: cost-effectiveness. BMJ 2000; 321: 1389-92.
32. Glick H, Polsky D, Schulman K. Trial-based economic evaluations: an overview of design and analysis. In Economic Evaluation in Health Care: Merging Theory with Practice (eds M Drummond, A McGuire): 113-40. Oxford University Press, 2001.
33. Layard, R. The case for psychological treatment centres. BMJ 2006; 332: 1030-2.
34. Waller R, Gilbody S, Waller R. Barriers to the uptake of computerized cognitive behavioural therapy: a systematic review of the quantitative and qualitative evidence. Psychol Med 2009; 39: 705-12.
35. Beattie A, Shaw A, Kaur S, Kessler RC. Primary care patients' expectations and experiences of online cognitive behavioural therapy for depression: a qualitative study. Health Expect 2009; 12: 45-59.